Literature DB >> 6260157

The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriation.

A A Piper, M H Tattersall, R M Fox.   

Abstract

The activities throughout the cell cycle of thymidine kinase (EC 2.7.1.21), dihydrothymine dehydrogenase (EC 1.3.1.2), thymidine phosphorylase (EC 2.4.2.4) and dTMP phosphatase (EC 3.3.3.35) were measured in the Epstein-Barr virally transformed human B lymphocyte line LAZ-007. Cells were synchronised at different stages of the cell cycle using the technique of centrifugal elutriation. The degree of synchrony in each cycle-stage cell population was determined by flow microfluorimetric analysis of DNA content and by measurement of thymidine incorporation into DNA. The activity of the anabolic enzyme thymidine kinase was low in the G1 phase cells, but increased manyfold during the S and G2 phases, reaching a maximum after the peak of DNA synthesis, then decreasing in late G2 + M phase. By contrast, the specific activities of the enzymes involved in thymidine and thymidylate catabolism, dihydrothymine dehydrogenase, thymidine phosphorylase and dTMP phosphatase remained essentially constant throughout the cell cycle, indicating that the fate of thymidine at different stages of the cell cycle is governed primarily by regulation of the level of the anabolic enzyme thymidine kinase and not by regulation of the levels of thymidine catabolising enzymes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6260157     DOI: 10.1016/0304-4165(80)90198-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  A new case of dihydropyrimidine dehydrogenase deficiency.

Authors:  M Brockstedt; C Jakobs; L M Smit; A H van Gennip; R Berger
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Cell cycle regulation of thymidine kinase: residues near the carboxyl terminus are essential for the specific degradation of the enzyme at mitosis.

Authors:  M G Kauffman; T J Kelly
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

3.  Dihydropyrimidine dehydrogenase deficiency leading to thymine-uraciluria. An inborn error of pyrimidine metabolism.

Authors:  S K Wadman; R Berger; M Duran; P K de Bree; S A Stoker-de Vries; F A Beemer; J J Weits-Binnerts; T J Penders; J K van der Woude
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  Dihydropyrimidine dehydrogenase deficiency--a further case.

Authors:  B Wilcken; J Hammond; R Berger; G Wise; C James
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

5.  Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.

Authors:  Xiaole Zhu; Chenyuan Shi; Yunpeng Peng; Lingdi Yin; Min Tu; Qiuyang Chen; Chaoqun Hou; Qiang Li; Yi Miao
Journal:  Cell Prolif       Date:  2017-12-20       Impact factor: 6.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.